154 related articles for article (PubMed ID: 11513341)
1. Neurocognitive symptoms and impairment in an HIV community clinic.
Kim DH; Jewison DL; Milner GR; Rourke SB; Gill MJ; Power C
Can J Neurol Sci; 2001 Aug; 28(3):228-31. PubMed ID: 11513341
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.
Cysique LA; Brew BJ
J Neurovirol; 2011 Apr; 17(2):176-83. PubMed ID: 21416169
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy.
Suarez S; Baril L; Stankoff B; Khellaf M; Dubois B; Lubetzki C; Bricaire F; Hauw JJ
AIDS; 2001 Jan; 15(2):195-200. PubMed ID: 11216927
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.
Cohen RA; Boland R; Paul R; Tashima KT; Schoenbaum EE; Celentano DD; Schuman P; Smith DK; Carpenter CC
AIDS; 2001 Feb; 15(3):341-5. PubMed ID: 11273214
[TBL] [Abstract][Full Text] [Related]
6. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment.
Tozzi V; Balestra P; Galgani S; Narciso P; Ferri F; Sebastiani G; D'Amato C; Affricano C; Pigorini F; Pau FM; De Felici A; Benedetto A
AIDS; 1999 Oct; 13(14):1889-97. PubMed ID: 10513647
[TBL] [Abstract][Full Text] [Related]
7. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART.
Tozzi V; Balestra P; Murri R; Galgani S; Bellagamba R; Narciso P; Antinori A; Giulianelli M; Tosi G; Fantoni M; Sampaolesi A; Noto P; Ippolito G; Wu AW
Int J STD AIDS; 2004 Apr; 15(4):254-9. PubMed ID: 15075020
[TBL] [Abstract][Full Text] [Related]
9. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.
Ammassari A; Antinori A; Aloisi MS; Trotta MP; Murri R; Bartoli L; Monforte AD; Wu AW; Starace F
Psychosomatics; 2004; 45(5):394-402. PubMed ID: 15345784
[TBL] [Abstract][Full Text] [Related]
10. Depressive symptoms and neurocognitive performance among HIV-infected women.
Fialho RM; Pereira M; Mendonça N; Ouakinin S
Women Health; 2013; 53(2):117-34. PubMed ID: 23517511
[TBL] [Abstract][Full Text] [Related]
11. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.
Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F
HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive functioning of HIV positive children attending the comprehensive care clinic at Kenyatta national hospital: exploring neurocognitive deficits and psychosocial risk factors.
Musindo O; Bangirana P; Kigamwa P; Okoth R; Kumar M
AIDS Care; 2018 May; 30(5):618-622. PubMed ID: 29353495
[TBL] [Abstract][Full Text] [Related]
13. Better quality of life with neuropsychological improvement on HAART.
Parsons TD; Braaten AJ; Hall CD; Robertson KR
Health Qual Life Outcomes; 2006 Feb; 4():11. PubMed ID: 16504114
[TBL] [Abstract][Full Text] [Related]
14. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings.
Cherner M; Ellis RJ; Lazzaretto D; Young C; Mindt MR; Atkinson JH; Grant I; Heaton RK;
AIDS; 2004 Jan; 18 Suppl 1():S27-34. PubMed ID: 15075495
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.
Royal W; Cherner M; Carr J; Habib AG; Akomolafe A; Abimiku A; Charurat M; Farley J; Oluyemisi A; Mamadu I; Johnson J; Ellis R; McCutchan JA; Grant I; Blattner WA
J Neurovirol; 2012 Jun; 18(3):191-9. PubMed ID: 22528480
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil.
de Almeida SM; Ribeiro CE; de Pereira AP; Badiee J; Cherner M; Smith D; Maich I; Raboni SM; Rotta I; Barbosa FJ; Heaton RK; Umlauf A; Ellis RJ
J Neurovirol; 2013 Dec; 19(6):550-6. PubMed ID: 24277437
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive functioning in acute or early HIV infection.
Moore DJ; Letendre SL; Morris S; Umlauf A; Deutsch R; Smith DM; Little S; Rooney A; Franklin DR; Gouaux B; Leblanc S; Rosario D; Fennema-Notestine C; Heaton RK; Ellis RJ; Atkinson JH; Grant I;
J Neurovirol; 2011 Feb; 17(1):50-7. PubMed ID: 21165782
[TBL] [Abstract][Full Text] [Related]
19. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.
Tozzi V; Balestra P; Bellagamba R; Corpolongo A; Salvatori MF; Visco-Comandini U; Vlassi C; Giulianelli M; Galgani S; Antinori A; Narciso P
J Acquir Immune Defic Syndr; 2007 Jun; 45(2):174-82. PubMed ID: 17356465
[TBL] [Abstract][Full Text] [Related]
20. Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia.
Kabuba N; Anitha Menon J; Franklin DR; Heaton RK; Hestad KA
AIDS Behav; 2017 Jun; 21(6):1717-1727. PubMed ID: 27278547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
